ERIN SHANNON: Open Payments
NPI 1376231241 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 21 payments from 11 companies in 2025. Trend: 2023 $160 · 2024 $430 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $91 |
| BridgeBio Pharma, Inc. | 4 | $71 |
| Actelion Pharmaceuticals US, Inc. | 2 | $54 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Lilly USA, LLC | 1 | $25 |
| ABIOMED | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
Products named: VERQUVO, Attruby, UPTRAVI, LifeVest, ZEPBOUND, WINREVAIR, SHINGRIX, LEQVIO.
Industry payments across NY — which companies pay providers there.
